Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Why Replimune Stock Is Soaring Today

TheMotleyFool

0 0

Shares of Replimune Group (NASDAQ: REPL) were soaring 13.3% higher as of 11:01 a.m. EDT on Thursday after rising as much as 22.4% earlier in the day. The big jump resulted from the company's announcement that it will present encouraging data from two early-stage clinical studies evaluating experimental immunotherapies RP1 and RP2 at the Society for Immunotherapy of Cancer (SITC) annual meeting in November.

Positive clinical news is exactly what a clinical-stage biotech stock like Replimune needs to get investors excited. The company's scheduled virtual poster presentations at SITC are indeed good news.

Image source: Getty Images.

Source Fool.com

Like: 0

REPL

Teilen